Author:
Judy Megan,Sams David,Poulton Stephon
Abstract
ABSTRACT
Cytochrome P450 enzyme metabolism is altered by environmental and genetic factors, which can affect the efficacy and safety of opioids. This article describes CYP polymorphisms and how pharmacogenetic testing could be used to help clinicians make safer decisions about opioid use in patients.
Publisher
Ovid Technologies (Wolters Kluwer Health)